John J. Normile

John has acted as trial counsel before several of the federal district and appellate courts including the Federal Circuit and the U.S. Supreme Court. He has represented pharmaceutical companies in the enforcement of patents concerning blockbuster drugs including OxyContin®, Butrans®, Hysingla®, Skelaxin®, Buspar®, and MitomycinC®. John also has experience representing clients as lead counsel in USPTO post-grant proceedings. These representations have involved at least 50 district court actions and various appearances in the USPTO and the Federal Circuit. John is an adjunct professor at Fordham Law School, where he has taught a course in patent litigation for the past 25 years.

His clients have consistently praised his approach to Hatch-Waxman cases: "John is brilliant at creating and executing great litigation strategies. He makes complicated matters simple and takes a comprehensive approach that goes beyond patent law to accomplish the goals of his clients. He's one of the best litigators for complex pharmaceutical matters." (IAM Patent 1000: The World's Leading Patent Professionals (2018)).

John is a member of the President's Council and the Parent Leadership Council at Fordham University, the Feerick Institute of Social Justice, the New York Archdiocese Inner-City Scholarship Fund and President of the Fordham Law School Alumni Association.